+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

BICO Group AB (BICO) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 54 Pages
  • May 2024
  • GlobalData
  • ID: 5577806
BICO Group AB (BICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BICO Group AB (BICO AB) is engaged in the development and marketing of bioprinting technologies which enable researchers to print three dimensional (3D) human organs and tissues. The company’s product portfolio encompasses bioprinters, drug screening, biodispensing solutions and automated non-contact plate washers and liquid dispenser, among others. It also offers spheroOne, the single large-particle sorter and dispenser platform. BICO caters to research institutions, pharmaceutical, biopharmaceutical, automotive, and cosmetic companies. The company sells its products through direct sales force in the US and Sweden and through an extensive network of distributors in Europe (excluding Sweden), and Asia-Pacific. It operates a subsidiary in the US. BICO AB is headquartered in Goteborg, Sweden.

BICO Group AB Key Recent Developments

  • Apr 18, 2024: Anders Fogelberg appointed as Chief Commercial Officer for BICO Group AB (publ
  • Jan 25, 2024: Catharina Nordlund is Appointed Global Head of HR for BICO Group AB (publ)
  • Jan 25, 2024: CELLINK and the University of California, San Diego Partner to Open a 3D Bioprinting Centre of Excellence
  • Nov 14, 2023: BICO Group Announces Publication of Interim Report July - September 2023

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • BICO Group AB - Key Facts
  • BICO Group AB - Key Employees
  • BICO Group AB - Key Employee Biographies
  • BICO Group AB - Major Products and Services
  • BICO Group AB - History
  • BICO Group AB - Company Statement
  • BICO Group AB - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • BICO Group AB - Business Description
  • Business Segment: Bioautomation
  • Overview
  • Performance
  • Business Segment: Bioprinting
  • Overview
  • Overview
  • Performance
  • Business Segment: Biosciences
  • Overview
  • Performance
  • Geographical Segment: Australia
  • Performance
  • Geographical Segment: Austria
  • Performance
  • Geographical Segment: Belgium
  • Performance
  • Geographical Segment: Canada
  • Performance
  • Geographical Segment: China
  • Performance
  • Geographical Segment: Denmark
  • Performance
  • Geographical Segment: Finland
  • Performance
  • Geographical Segment: France
  • Performance
  • Geographical Segment: Germany
  • Performance
  • Geographical Segment: Hong Kong
  • Performance
  • Geographical Segment: Ireland
  • Performance
  • Geographical Segment: Israel
  • Performance
  • Geographical Segment: Italy
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: Netherlands
  • Performance
  • Geographical Segment: Other
  • Performance
  • Geographical Segment: Singapore
  • Performance
  • Geographical Segment: South Korea
  • Performance
  • Geographical Segment: Spain
  • Performance
  • Geographical Segment: Sweden
  • Performance
  • Geographical Segment: Switzerland
  • Performance
  • Geographical Segment: Taiwan
  • Performance
  • Geographical Segment: UK
  • Performance
  • Geographical Segment: USA
  • Performance
  • R&D Overview
  • BICO Group AB - Corporate Strategy
  • BICO Group AB - SWOT Analysis
  • SWOT Analysis - Overview
  • BICO Group AB - Strengths
  • BICO Group AB - Weaknesses
  • BICO Group AB - Opportunities
  • BICO Group AB - Threats
  • BICO Group AB - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • BICO Group AB, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • BICO Group AB, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • BICO Group AB, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 18, 2024: Anders Fogelberg appointed as Chief Commercial Officer for BICO Group AB (publ
  • Jan 25, 2024: Catharina Nordlund is Appointed Global Head of HR for BICO Group AB (publ)
  • Jan 25, 2024: CELLINK and the University of California, San Diego Partner to Open a 3D Bioprinting Centre of Excellence
  • Nov 14, 2023: BICO Group Announces Publication of Interim Report July - September 2023
  • Nov 01, 2023: BICO Releases Preliminary Revenue, EBITDA, and Cash Flow From Operating Activities for Q3, 2023
  • Aug 22, 2023: Publication of BICO Group interim report April - June 2023
  • Aug 21, 2023: Maria Forss is appointed new President and CEO of BICO Group AB (publ
  • May 09, 2023: BICO Group announces bulletin from annual general meeting
  • May 09, 2023: Bulletin from Annual General Meeting in BICO Group AB (publ
  • May 04, 2023: Publication of BICO Group interim report January - March 2023
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • BICO Group AB, Key Facts
  • BICO Group AB, Key Employees
  • BICO Group AB, Key Employee Biographies
  • BICO Group AB, Major Products and Services
  • BICO Group AB, History
  • BICO Group AB, Subsidiaries
  • BICO Group AB, Key Competitors
  • BICO Group AB, Ratios based on current share price
  • BICO Group AB, Annual Ratios
  • BICO Group AB, Interim Ratios
  • BICO Group AB, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • BICO Group AB, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • BICO Group AB, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • BICO Group AB, Performance Chart (2019 - 2023)
  • BICO Group AB, Ratio Charts
  • BICO Group AB, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • BICO Group AB, Medical Equipment, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • DexCom Inc
  • Abbott Laboratories
  • Align Technology Inc
  • Materialise NV